The effectiveness of hyperbaric oxygen therapy to the final outcome of patients with sudden sensorineural hearing loss.

Not Applicable

Completed

• Conditions: Sudden sensorineural hearing loss; Ear - Deafness

• Registration Number: ACTRN12616001359426
• Lead Sponsor: Medical School of Aristotle University of Thessaloniki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-09-29
• Study Completion: 2019-09-23
• Last Update Posted: 28 June 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Idiopathic sudden sensorineural hearing loss

Exclusion Criteria

1)Patients with bilateral sudden sensorineural hearing loss.
2)Patients who seek assistance after more than 7 days from the presence of symptoms.
3)Patients who have already received another treatment for sudden sensorineural hearing loss.
4)Patients with other causes of sudden sensorineural hearing loss such as autoimmune disease, Meniere disease, use of ototoxic agents, syphilis, trauma.
5)Acoustic neuroma or demyelinating disease in MRI or other lesion in the cerebellopontine angle.
6)Patients younger than 18 years old.
7)Pregnancy.
8) Contraindications to HBOT such as tension or untreated or recent pneumothorax, administration of certain drugs (Bleomycin, Cisplatin, Disulfiram, Doxorubicin), untreated epilepsy or seizures, congenital spherocytosis, upper respiratory infection, heart failure, chronic obstructive pulmonary disease, claustrophobia.
9)Glaucoma.
10)Mental disorders.
11)Middle ear disease.
12)Diabetes mellitus.
13)Difficult to treat hypertension.
14)Contraindications of steroids administration (peptic ulcer disease, osteoporosis, immunosuppression).

Study & Design

• Study Type: Interventional
• Study Design: Not specified